title: Bone mineral density in patients with rheumatoid arthritis treated with infliximab.
authors.forename: M
authors.initials: M
authors.lastname: Vis
authors.forename: A E
authors.initials: AE
authors.lastname: Voskuyl
authors.forename: G J
authors.initials: GJ
authors.lastname: Wolbink
authors.forename: B A C
authors.initials: BA
authors.lastname: Dijkmans
authors.forename: W F
authors.initials: WF
authors.lastname: Lems
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab